- Home
- CLFD vs VALN Comparison
CLFD vs VALN Comparison
Compare CLFD & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLFD
- VALN
- Stock Information
- Founded
- CLFD 1979
- VALN 2012
- Country
- CLFD United States
- VALN France
- Employees
- CLFD N/A
- VALN N/A
- Industry
- CLFD Telecommunications Equipment
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLFD Utilities
- VALN Health Care
- Exchange
- CLFD Nasdaq
- VALN Nasdaq
- Market Cap
- CLFD 426.1M
- VALN 510.7M
- IPO Year
- CLFD N/A
- VALN 2021
- Fundamental
- Price
- CLFD $37.11
- VALN $6.40
- Analyst Decision
- CLFD Strong Buy
- VALN Strong Buy
- Analyst Count
- CLFD 3
- VALN 3
- Target Price
- CLFD $46.67
- VALN $15.33
- AVG Volume (30 Days)
- CLFD 185.2K
- VALN 83.3K
- Earning Date
- CLFD 05-08-2025
- VALN 05-07-2025
- Dividend Yield
- CLFD N/A
- VALN N/A
- EPS Growth
- CLFD N/A
- VALN N/A
- EPS
- CLFD N/A
- VALN N/A
- Revenue
- CLFD $178,209,000.00
- VALN $201,099,222.00
- Revenue This Year
- CLFD $10.77
- VALN $18.74
- Revenue Next Year
- CLFD $14.46
- VALN $29.26
- P/E Ratio
- CLFD N/A
- VALN N/A
- Revenue Growth
- CLFD N/A
- VALN 21.64
- 52 Week Low
- CLFD $23.78
- VALN $3.62
- 52 Week High
- CLFD $44.83
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- CLFD 61.72
- VALN 48.49
- Support Level
- CLFD $37.49
- VALN $6.18
- Resistance Level
- CLFD $38.98
- VALN $6.54
- Average True Range (ATR)
- CLFD 1.52
- VALN 0.21
- MACD
- CLFD -0.21
- VALN 0.01
- Stochastic Oscillator
- CLFD 56.54
- VALN 54.35
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.